BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE
NDC 71335-1858, BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE, tablet, from Bryant Ranch Prepack.
- Product NDC
- 71335-1858
- Status
- Listed
- Labeler
- Bryant Ranch Prepack
- Dosage form
- TABLET
- Route
- SUBLINGUAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209069
- DEA schedule
- CIII
curl https://api.healthcare.dev/v1/drugs/ndc/71335-1858 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUPRENORPHINE HYDROCHLORIDE8 mg/1
- NALOXONE HYDROCHLORIDE DIHYDRATE2 mg/1
Pharmacologic classes
Opioid Antagonist [EPC]; Opioid Antagonists [MoA]; Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71335-1858-0 | 71335185800 | 42 TABLET in 1 BOTTLE, PLASTIC (71335-1858-0) |
| 71335-1858-1 | 71335185801 | 30 TABLET in 1 BOTTLE, PLASTIC (71335-1858-1) |
| 71335-1858-2 | 71335185802 | 60 TABLET in 1 BOTTLE, PLASTIC (71335-1858-2) |
| 71335-1858-3 | 71335185803 | 90 TABLET in 1 BOTTLE, PLASTIC (71335-1858-3) |
| 71335-1858-4 | 71335185804 | 120 TABLET in 1 BOTTLE, PLASTIC (71335-1858-4) |
| 71335-1858-5 | 71335185805 | 14 TABLET in 1 BOTTLE, PLASTIC (71335-1858-5) |
| 71335-1858-6 | 71335185806 | 28 TABLET in 1 BOTTLE, PLASTIC (71335-1858-6) |
| 71335-1858-7 | 71335185807 | 6 TABLET in 1 BOTTLE, PLASTIC (71335-1858-7) |
| 71335-1858-8 | 71335185808 | 10 TABLET in 1 BOTTLE, PLASTIC (71335-1858-8) |
| 71335-1858-9 | 71335185809 | 21 TABLET in 1 BOTTLE, PLASTIC (71335-1858-9) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/53457b0d-3462-489e-8cf5-7cdc2ecffb48
Use it
Look up 71335-1858 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71335-1858 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71335-1858. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.